The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pivotal Bioventure Partners Fund I U.g.p. Ltd since 2018.
This trader's CIK number is 1752847.
At the time of last reporting, Pivotal Bioventure Partners Fund I U.g.p. Ltd was the Officer of Inozyme Pharma, Inc.. (stock ticker symbol INZY).
Also see all insider trading activities at Inozyme Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | INZY | 833,333 | $3,999,998 | 0 | $0 | 0 | $0 |
| 2022 | INZY | 1,070,000 | $3,948,300 | 0 | $0 | 0 | $0 |
| 2020 | INZY | 187,500 | $3,000,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | ETTX | 337,724 | $5,065,860 | 0 | $0 | 0 | $0 |
1. Inozyme Pharma, Inc. (INZY)
2. Entasis Therapeutics Holdings Inc. (ETTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-01 | INZY | Buy | 833,333 | 4.80 | 3,999,998 |
| 2022-04-19 | INZY | Buy | 1,070,000 | 3.69 | 3,948,300 |
| 2020-07-28 | INZY | Buy | 187,500 | 16.00 | 3,000,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-09-28 | ETTX | Buy | 337,724 | 15.00 | 5,065,860 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Pivotal Bioventure Partners Fund I U.g.p. Ltd (Officer of Inozyme Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.